Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-23

FDA Approved: IRINOTECAN HYDROCHLORIDE — Supplemental Application (Sagent Pharmaceuticals)

View source ↗

Summary

The FDA approved a supplemental application for irinotecan hydrochloride submitted by Sagent Pharmaceuticals, indicating an approval of changes to the product u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IRINOTECAN HYDROCHLORIDE (irinotecan hydrochloride)

Snippet

SUPPL AP for IRINOTECAN HYDROCHLORIDE (IRINOTECAN HYDROCHLORIDE)